Ikarian Capital’s Ventyx Biosciences VTYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,233
Closed -$4.28M 184
2023
Q3
$4.28M Sell
1,233
-372,867
-100% -$12.9M 0.52% 52
2023
Q2
$12.3M Buy
+374,100
New +$12.9M 1.95% 10

Other funds holding VTYX

Ikarian Capital's VTYX Position: Q1 2026 in Review

Ikarian Capital sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 958,704 shares — an estimated $8.66M sold.

Ikarian Capital first reported a position in VTYX in Q1 2023 and held it in 10 quarters. The position peaked at $8.66M in Q4 2025. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

  • Ikarian Capital reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
  • Ikarian Capital sold 958,704 Ventyx Biosciences shares in Q1 2026, an estimated $8.66M.
  • Ikarian Capital first reported a position in Ventyx Biosciences in Q1 2023 and held it in 10 quarters.
  • Ikarian Capital's Ventyx Biosciences position peaked at $8.66M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on Ikarian Capital's 13F filing for Q1 2026, filed 15 May 2026.